scholarly journals Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial

2013 ◽  
Vol 24 (1) ◽  
pp. 165-171 ◽  
Author(s):  
A.Y.B. Teoh ◽  
P.W.Y. Chiu ◽  
W.K. Yeung ◽  
S.Y.W. Liu ◽  
S.K.H. Wong ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Squamous Carcinoma ◽  
Survival Outcomes ◽  
Term Survival ◽  
Carcinoma Of The Esophagus ◽  
Long Term Survival ◽  
Randomized Controlled ◽  
Definitive Chemoradiation

scholarly journals Coincidence vs Cause: Cure in Three Glioblastoma Patients Treated with Brachytherapy

2007 ◽  
Vol 34 (3) ◽  
pp. 339-342 ◽  
Author(s):  
Amir R. Dehdashti ◽  
Sunjay Sharma ◽  
Normand Laperriere ◽  
Mark Bernstein
Keyword(s):  
Randomized Controlled Trial ◽  
Statistical Analysis ◽  
Case Reports ◽  
Controlled Trial ◽  
Individual Case ◽  
Term Survival ◽  
Randomized Controlled ◽  
Iodine 125 ◽  
Fractionated Radiation

Background:Very long term survival after diagnosis of malignant glioma has been described in individual case reports. Survival of more than 10 years is extremely rare, especially when identified in 3 out of 71 patients assigned to one arm of a randomized controlled trial.Patients:Three patients survived 11, 16, and 18 years following the diagnosis of glioblastoma and treatment with surgery, conventional fractionated radiation, and high-activity iodine-125 boost brachytherapy as part of a randomized controlled trial.Conclusion:Despite this apparent cause and effect relationship, statistical analysis shows no relationship between these cures and treatment with brachytherapy. Cure of glioblastoma remains rare.

Sign in / Sign up

Export Citation Format

Share Document